Amanote Research
Register
Sign In
A Novel Series of Potent and Selective PDE5 Inhibitors With Potential for High and Dose-Independent Oral Bioavailability
doi 10.1021/jm060113e.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
Investigation of PDE5/PDE6 and PDE5/PDE11 Selective Potent Tadalafil-Like PDE5 Inhibitors Using Combination of Molecular Modeling Approaches, Molecular Fingerprint-Based Virtual Screening Protocols and Structure-Based Pharmacophore Development
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Potent and Selective Inhibitors of Human Sirtuin 5
At Long Last Potent and Selective KDM5 Inhibitors
Cell Chemical Biology
Molecular Medicine
Molecular Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Drug Discovery
Structure-Based Design of Potent and Selective CK1γ Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
ABT-538 Is a Potent Inhibitor of Human Immunodeficiency Virus Protease and Has High Oral Bioavailability in Humans.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and StructureActivity Relationships
Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and StructureActivity Relationships
Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and StructureActivity Relationships
